aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Sirius Therapeutics, based in San Diego, California, is a pioneering biotechnology company dedicated to developing RNA interference (RNAi) therapies for cardiovascular diseases. The company's mission is to leverage RNAi technology to create innovative medical solutions that address significant cardiovascular risks globally. By focusing on novel RNAi therapies, Sirius aims to change the future of cardiovascular disease treatment and improve patient outcomes worldwide.
Sirius Therapeutics has made significant strides in advancing its RNAi therapies, including the recent milestone of dosing the first subject in a clinical trial in China. This achievement underscores the company's commitment to global healthcare innovation and its potential impact on cardiovascular disease management. Through its cutting-edge research and development efforts, Sirius Therapeutics is poised to make a substantial contribution to the field of biotechnology and patient care.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Rnai Therapies
Technology
Biotech, RNAI
Tags
Therapeutics
Model Types
Recurring
Revenue Type(s)
Healthcare
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Sirius Therapeutics founded?
Sirius Therapeutics was founded in 2021.
Where is Sirius Therapeutics's headquarters located?
Sirius Therapeutics's headquarters is located in San Diego, CA, US.
When was Sirius Therapeutics's last funding round?
Sirius Therapeutics's most recent funding round was for $60M (USD) in October 2023.
How many employees does Sirius Therapeutics have?
Sirius Therapeutics has 5 employees as of Feb 4, 2024.
How much has Sirius Therapeutics raised to-date?
As of July 05, 2023, Sirius Therapeutics has raised a total of $60M (USD) since Oct 9, 2023.
Add Comparison
Total Raised to Date
$60M
USD
Last Update Oct 9, 2023
Last Deal Details
$60M
USD
Oct 9, 2023
Series B
Total Employees Over Time
5
As of Feb 2024
Sirius Therapeutics Address
11760 Sorrento Valley Road
San Diego,
California
92121
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts